ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Identifieur interne : 000229 ( PascalFrancis/Corpus ); précédent : 000228; suivant : 000230ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Auteurs : F. Cardoso ; A. Costa ; L. Norton ; E. Senkus ; M. Aapro ; F. Andre ; C. H. Barrios ; J. Bergh ; L. Biganzoli ; K. L. Blackwell ; M. J. Cardoso ; T. Cufer ; N. El Saghir ; L. Fallowfield ; D. Fenech ; P. Francis ; K. Gelmon ; S. H. Giordano ; J. Gligorov ; A. Goldhirsch ; N. Harbeck ; N. Houssami ; C. Hudis ; B. Kaufman ; I. Krop ; S. Kyriakides ; U. N. Lin ; M. Mayer ; S. D. Merjaver ; E. B. Nordström ; O. Pagani ; A. Partridge ; F. Penault-Llorca ; M. J. Piccart ; H. Rugo ; G. Sledge ; C. Thomssen ; L. Van'T Veer ; D. Vorobiof ; C. Vrieling ; N. West ; B. Xu ; E. WinerSource :
- Annals of oncology [ 0923-7534 ] ; 2014.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 14-0252642 INIST |
---|---|
ET : | ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) |
AU : | CARDOSO (F.); COSTA (A.); NORTON (L.); SENKUS (E.); AAPRO (M.); ANDRE (F.); BARRIOS (C. H.); BERGH (J.); BIGANZOLI (L.); BLACKWELL (K. L.); CARDOSO (M. J.); CUFER (T.); EL SAGHIR (N.); FALLOWFIELD (L.); FENECH (D.); FRANCIS (P.); GELMON (K.); GIORDANO (S. H.); GLIGOROV (J.); GOLDHIRSCH (A.); HARBECK (N.); HOUSSAMI (N.); HUDIS (C.); KAUFMAN (B.); KROP (I.); KYRIAKIDES (S.); LIN (U. N.); MAYER (M.); MERJAVER (S. D.); NORDSTRÖM (E. B.); PAGANI (O.); PARTRIDGE (A.); PENAULT-LLORCA (F.); PICCART (M. J.); RUGO (H.); SLEDGE (G.); THOMSSEN (C.); VAN'T VEER (L.); VOROBIOF (D.); VRIELING (C.); WEST (N.); XU (B.); WINER (E.) |
AF : | European School of Oncology & Breast Unit, Champalimaud Cancer Center/Lisbon/Portugal (1 aut.); European School of Oncology/Milan/Italie (2 aut.); European School of Oncology/Bellinzona/Suisse (2 aut.); Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre/New York/Etats-Unis (3 aut.); Department of Oncology and Radiotherapy, Medical University of Gdansk/Gdansk/Pologne (4 aut.); Division of Oncology, Institut Multidisciplinaire d'Oncologie/Genolier/Suisse (5 aut.); Department of Medical Oncology, Gustave-Roussy Institute/Villejuif/France (6 aut.); Department of Medicine, PUCRS School of Medicine/Porto Alegre/Brésil (7 aut.); Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital/Stockholm/Suède (8 aut.); Department of Medical Oncology, Sandro Pitigliani Oncology Centre/Prato/Italie (9 aut.); Breast Cancer Clinical Program, Duke Cancer Institute/Durham/Etats-Unis (10 aut.); Breast Unit, Champalimaud Cancer Center/Lisbon/Portugal (11 aut.); University Clinic Golnik, Medical Faculty Ljubljana/Ljubljana/Slovénie (12 aut.); NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center/Beirut/Liban (13 aut.); Brighton & Sussex Medical School, University of Sussex/Falmer/Royaume-Uni (14 aut.); Breast Care Support Group, Europa Donna Malta/Mtarfa/Malte (15 aut.); Division of Cancer Medicine, Peter MacCallum Cancer Centre/Melbourne/Australie (16 aut.); BC Cancer Agency/Vancouver/Canada (17 aut.); Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center/Houston/Etats-Unis (18 aut.); APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME/Paris/France (19 aut.); Program of Breast Health, European Institute of Oncology/Milan/Italie (20 aut.); Brustzentrum der Universität München/Munich/Danemark (21 aut.); Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney/Sydney/Australie (22 aut.); Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center/New York/Etats-Unis (23 aut.); Sheba Medical Center/Tel Hashomer/Israël (24 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Annals of oncology; ISSN 0923-7534; Royaume-Uni; Da. 2014; Vol. 25; No. 10; Pp. 1871-1888; Bibl. 130 ref. |
LA : | Anglais |
CC : | 002B02R; 002B20E02; 002B04C |
FD : | International; Consensus; Recommandation; Stade avancé; Cancer du sein |
FG : | Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein |
ED : | International; Consensus; Recommendation; Advanced stage; Breast cancer |
EG : | Malignant tumor; Cancer; Mammary gland diseases; Breast disease |
SD : | Internacional; Consenso; Recomendación; Estadio avanzado; Cáncer del pecho |
LO : | INIST-22429.354000504540330020 |
ID : | 14-0252642 |
Links to Exploration step
Pascal:14-0252642Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)</title>
<author><name sortKey="Cardoso, F" sort="Cardoso, F" uniqKey="Cardoso F" first="F." last="Cardoso">F. Cardoso</name>
<affiliation><inist:fA14 i1="01"><s1>European School of Oncology & Breast Unit, Champalimaud Cancer Center</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Costa, A" sort="Costa, A" uniqKey="Costa A" first="A." last="Costa">A. Costa</name>
<affiliation><inist:fA14 i1="02"><s1>European School of Oncology</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>European School of Oncology</s1>
<s2>Bellinzona</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Norton, L" sort="Norton, L" uniqKey="Norton L" first="L." last="Norton">L. Norton</name>
<affiliation><inist:fA14 i1="04"><s1>Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Senkus, E" sort="Senkus, E" uniqKey="Senkus E" first="E." last="Senkus">E. Senkus</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Oncology and Radiotherapy, Medical University of Gdansk</s1>
<s2>Gdansk</s2>
<s3>POL</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Aapro, M" sort="Aapro, M" uniqKey="Aapro M" first="M." last="Aapro">M. Aapro</name>
<affiliation><inist:fA14 i1="06"><s1>Division of Oncology, Institut Multidisciplinaire d'Oncologie</s1>
<s2>Genolier</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Andre, F" sort="Andre, F" uniqKey="Andre F" first="F." last="Andre">F. Andre</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Medical Oncology, Gustave-Roussy Institute</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Barrios, C H" sort="Barrios, C H" uniqKey="Barrios C" first="C. H." last="Barrios">C. H. Barrios</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Medicine, PUCRS School of Medicine</s1>
<s2>Porto Alegre</s2>
<s3>BRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bergh, J" sort="Bergh, J" uniqKey="Bergh J" first="J." last="Bergh">J. Bergh</name>
<affiliation><inist:fA14 i1="09"><s1>Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Biganzoli, L" sort="Biganzoli, L" uniqKey="Biganzoli L" first="L." last="Biganzoli">L. Biganzoli</name>
<affiliation><inist:fA14 i1="10"><s1>Department of Medical Oncology, Sandro Pitigliani Oncology Centre</s1>
<s2>Prato</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Blackwell, K L" sort="Blackwell, K L" uniqKey="Blackwell K" first="K. L." last="Blackwell">K. L. Blackwell</name>
<affiliation><inist:fA14 i1="11"><s1>Breast Cancer Clinical Program, Duke Cancer Institute</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cardoso, M J" sort="Cardoso, M J" uniqKey="Cardoso M" first="M. J." last="Cardoso">M. J. Cardoso</name>
<affiliation><inist:fA14 i1="12"><s1>Breast Unit, Champalimaud Cancer Center</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cufer, T" sort="Cufer, T" uniqKey="Cufer T" first="T." last="Cufer">T. Cufer</name>
<affiliation><inist:fA14 i1="13"><s1>University Clinic Golnik, Medical Faculty Ljubljana</s1>
<s2>Ljubljana</s2>
<s3>SVN</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="El Saghir, N" sort="El Saghir, N" uniqKey="El Saghir N" first="N." last="El Saghir">N. El Saghir</name>
<affiliation><inist:fA14 i1="14"><s1>NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center</s1>
<s2>Beirut</s2>
<s3>LBN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fallowfield, L" sort="Fallowfield, L" uniqKey="Fallowfield L" first="L." last="Fallowfield">L. Fallowfield</name>
<affiliation><inist:fA14 i1="15"><s1>Brighton & Sussex Medical School, University of Sussex</s1>
<s2>Falmer</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fenech, D" sort="Fenech, D" uniqKey="Fenech D" first="D." last="Fenech">D. Fenech</name>
<affiliation><inist:fA14 i1="16"><s1>Breast Care Support Group, Europa Donna Malta</s1>
<s2>Mtarfa</s2>
<s3>MLT</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Francis, P" sort="Francis, P" uniqKey="Francis P" first="P." last="Francis">P. Francis</name>
<affiliation><inist:fA14 i1="17"><s1>Division of Cancer Medicine, Peter MacCallum Cancer Centre</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gelmon, K" sort="Gelmon, K" uniqKey="Gelmon K" first="K." last="Gelmon">K. Gelmon</name>
<affiliation><inist:fA14 i1="18"><s1>BC Cancer Agency</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Giordano, S H" sort="Giordano, S H" uniqKey="Giordano S" first="S. H." last="Giordano">S. H. Giordano</name>
<affiliation><inist:fA14 i1="19"><s1>Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center</s1>
<s2>Houston</s2>
<s3>USA</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gligorov, J" sort="Gligorov, J" uniqKey="Gligorov J" first="J." last="Gligorov">J. Gligorov</name>
<affiliation><inist:fA14 i1="20"><s1>APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goldhirsch, A" sort="Goldhirsch, A" uniqKey="Goldhirsch A" first="A." last="Goldhirsch">A. Goldhirsch</name>
<affiliation><inist:fA14 i1="21"><s1>Program of Breast Health, European Institute of Oncology</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harbeck, N" sort="Harbeck, N" uniqKey="Harbeck N" first="N." last="Harbeck">N. Harbeck</name>
<affiliation><inist:fA14 i1="22"><s1>Brustzentrum der Universität München</s1>
<s2>Munich</s2>
<s3>DNK</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Houssami, N" sort="Houssami, N" uniqKey="Houssami N" first="N." last="Houssami">N. Houssami</name>
<affiliation><inist:fA14 i1="23"><s1>Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hudis, C" sort="Hudis, C" uniqKey="Hudis C" first="C." last="Hudis">C. Hudis</name>
<affiliation><inist:fA14 i1="24"><s1>Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaufman, B" sort="Kaufman, B" uniqKey="Kaufman B" first="B." last="Kaufman">B. Kaufman</name>
<affiliation><inist:fA14 i1="25"><s1>Sheba Medical Center</s1>
<s2>Tel Hashomer</s2>
<s3>ISR</s3>
<sZ>24 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krop, I" sort="Krop, I" uniqKey="Krop I" first="I." last="Krop">I. Krop</name>
</author>
<author><name sortKey="Kyriakides, S" sort="Kyriakides, S" uniqKey="Kyriakides S" first="S." last="Kyriakides">S. Kyriakides</name>
</author>
<author><name sortKey="Lin, U N" sort="Lin, U N" uniqKey="Lin U" first="U. N." last="Lin">U. N. Lin</name>
</author>
<author><name sortKey="Mayer, M" sort="Mayer, M" uniqKey="Mayer M" first="M." last="Mayer">M. Mayer</name>
</author>
<author><name sortKey="Merjaver, S D" sort="Merjaver, S D" uniqKey="Merjaver S" first="S. D." last="Merjaver">S. D. Merjaver</name>
</author>
<author><name sortKey="Nordstrom, E B" sort="Nordstrom, E B" uniqKey="Nordstrom E" first="E. B." last="Nordström">E. B. Nordström</name>
</author>
<author><name sortKey="Pagani, O" sort="Pagani, O" uniqKey="Pagani O" first="O." last="Pagani">O. Pagani</name>
</author>
<author><name sortKey="Partridge, A" sort="Partridge, A" uniqKey="Partridge A" first="A." last="Partridge">A. Partridge</name>
</author>
<author><name sortKey="Penault Llorca, F" sort="Penault Llorca, F" uniqKey="Penault Llorca F" first="F." last="Penault-Llorca">F. Penault-Llorca</name>
</author>
<author><name sortKey="Piccart, M J" sort="Piccart, M J" uniqKey="Piccart M" first="M. J." last="Piccart">M. J. Piccart</name>
</author>
<author><name sortKey="Rugo, H" sort="Rugo, H" uniqKey="Rugo H" first="H." last="Rugo">H. Rugo</name>
</author>
<author><name sortKey="Sledge, G" sort="Sledge, G" uniqKey="Sledge G" first="G." last="Sledge">G. Sledge</name>
</author>
<author><name sortKey="Thomssen, C" sort="Thomssen, C" uniqKey="Thomssen C" first="C." last="Thomssen">C. Thomssen</name>
</author>
<author><name sortKey="Van T Veer, L" sort="Van T Veer, L" uniqKey="Van T Veer L" first="L." last="Van'T Veer">L. Van'T Veer</name>
</author>
<author><name sortKey="Vorobiof, D" sort="Vorobiof, D" uniqKey="Vorobiof D" first="D." last="Vorobiof">D. Vorobiof</name>
</author>
<author><name sortKey="Vrieling, C" sort="Vrieling, C" uniqKey="Vrieling C" first="C." last="Vrieling">C. Vrieling</name>
</author>
<author><name sortKey="West, N" sort="West, N" uniqKey="West N" first="N." last="West">N. West</name>
</author>
<author><name sortKey="Xu, B" sort="Xu, B" uniqKey="Xu B" first="B." last="Xu">B. Xu</name>
</author>
<author><name sortKey="Winer, E" sort="Winer, E" uniqKey="Winer E" first="E." last="Winer">E. Winer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0252642</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0252642 INIST</idno>
<idno type="RBID">Pascal:14-0252642</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000229</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)</title>
<author><name sortKey="Cardoso, F" sort="Cardoso, F" uniqKey="Cardoso F" first="F." last="Cardoso">F. Cardoso</name>
<affiliation><inist:fA14 i1="01"><s1>European School of Oncology & Breast Unit, Champalimaud Cancer Center</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Costa, A" sort="Costa, A" uniqKey="Costa A" first="A." last="Costa">A. Costa</name>
<affiliation><inist:fA14 i1="02"><s1>European School of Oncology</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>European School of Oncology</s1>
<s2>Bellinzona</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Norton, L" sort="Norton, L" uniqKey="Norton L" first="L." last="Norton">L. Norton</name>
<affiliation><inist:fA14 i1="04"><s1>Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Senkus, E" sort="Senkus, E" uniqKey="Senkus E" first="E." last="Senkus">E. Senkus</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Oncology and Radiotherapy, Medical University of Gdansk</s1>
<s2>Gdansk</s2>
<s3>POL</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Aapro, M" sort="Aapro, M" uniqKey="Aapro M" first="M." last="Aapro">M. Aapro</name>
<affiliation><inist:fA14 i1="06"><s1>Division of Oncology, Institut Multidisciplinaire d'Oncologie</s1>
<s2>Genolier</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Andre, F" sort="Andre, F" uniqKey="Andre F" first="F." last="Andre">F. Andre</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Medical Oncology, Gustave-Roussy Institute</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Barrios, C H" sort="Barrios, C H" uniqKey="Barrios C" first="C. H." last="Barrios">C. H. Barrios</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Medicine, PUCRS School of Medicine</s1>
<s2>Porto Alegre</s2>
<s3>BRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bergh, J" sort="Bergh, J" uniqKey="Bergh J" first="J." last="Bergh">J. Bergh</name>
<affiliation><inist:fA14 i1="09"><s1>Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Biganzoli, L" sort="Biganzoli, L" uniqKey="Biganzoli L" first="L." last="Biganzoli">L. Biganzoli</name>
<affiliation><inist:fA14 i1="10"><s1>Department of Medical Oncology, Sandro Pitigliani Oncology Centre</s1>
<s2>Prato</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Blackwell, K L" sort="Blackwell, K L" uniqKey="Blackwell K" first="K. L." last="Blackwell">K. L. Blackwell</name>
<affiliation><inist:fA14 i1="11"><s1>Breast Cancer Clinical Program, Duke Cancer Institute</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cardoso, M J" sort="Cardoso, M J" uniqKey="Cardoso M" first="M. J." last="Cardoso">M. J. Cardoso</name>
<affiliation><inist:fA14 i1="12"><s1>Breast Unit, Champalimaud Cancer Center</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cufer, T" sort="Cufer, T" uniqKey="Cufer T" first="T." last="Cufer">T. Cufer</name>
<affiliation><inist:fA14 i1="13"><s1>University Clinic Golnik, Medical Faculty Ljubljana</s1>
<s2>Ljubljana</s2>
<s3>SVN</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="El Saghir, N" sort="El Saghir, N" uniqKey="El Saghir N" first="N." last="El Saghir">N. El Saghir</name>
<affiliation><inist:fA14 i1="14"><s1>NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center</s1>
<s2>Beirut</s2>
<s3>LBN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fallowfield, L" sort="Fallowfield, L" uniqKey="Fallowfield L" first="L." last="Fallowfield">L. Fallowfield</name>
<affiliation><inist:fA14 i1="15"><s1>Brighton & Sussex Medical School, University of Sussex</s1>
<s2>Falmer</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fenech, D" sort="Fenech, D" uniqKey="Fenech D" first="D." last="Fenech">D. Fenech</name>
<affiliation><inist:fA14 i1="16"><s1>Breast Care Support Group, Europa Donna Malta</s1>
<s2>Mtarfa</s2>
<s3>MLT</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Francis, P" sort="Francis, P" uniqKey="Francis P" first="P." last="Francis">P. Francis</name>
<affiliation><inist:fA14 i1="17"><s1>Division of Cancer Medicine, Peter MacCallum Cancer Centre</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gelmon, K" sort="Gelmon, K" uniqKey="Gelmon K" first="K." last="Gelmon">K. Gelmon</name>
<affiliation><inist:fA14 i1="18"><s1>BC Cancer Agency</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Giordano, S H" sort="Giordano, S H" uniqKey="Giordano S" first="S. H." last="Giordano">S. H. Giordano</name>
<affiliation><inist:fA14 i1="19"><s1>Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center</s1>
<s2>Houston</s2>
<s3>USA</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gligorov, J" sort="Gligorov, J" uniqKey="Gligorov J" first="J." last="Gligorov">J. Gligorov</name>
<affiliation><inist:fA14 i1="20"><s1>APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goldhirsch, A" sort="Goldhirsch, A" uniqKey="Goldhirsch A" first="A." last="Goldhirsch">A. Goldhirsch</name>
<affiliation><inist:fA14 i1="21"><s1>Program of Breast Health, European Institute of Oncology</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harbeck, N" sort="Harbeck, N" uniqKey="Harbeck N" first="N." last="Harbeck">N. Harbeck</name>
<affiliation><inist:fA14 i1="22"><s1>Brustzentrum der Universität München</s1>
<s2>Munich</s2>
<s3>DNK</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Houssami, N" sort="Houssami, N" uniqKey="Houssami N" first="N." last="Houssami">N. Houssami</name>
<affiliation><inist:fA14 i1="23"><s1>Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hudis, C" sort="Hudis, C" uniqKey="Hudis C" first="C." last="Hudis">C. Hudis</name>
<affiliation><inist:fA14 i1="24"><s1>Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaufman, B" sort="Kaufman, B" uniqKey="Kaufman B" first="B." last="Kaufman">B. Kaufman</name>
<affiliation><inist:fA14 i1="25"><s1>Sheba Medical Center</s1>
<s2>Tel Hashomer</s2>
<s3>ISR</s3>
<sZ>24 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krop, I" sort="Krop, I" uniqKey="Krop I" first="I." last="Krop">I. Krop</name>
</author>
<author><name sortKey="Kyriakides, S" sort="Kyriakides, S" uniqKey="Kyriakides S" first="S." last="Kyriakides">S. Kyriakides</name>
</author>
<author><name sortKey="Lin, U N" sort="Lin, U N" uniqKey="Lin U" first="U. N." last="Lin">U. N. Lin</name>
</author>
<author><name sortKey="Mayer, M" sort="Mayer, M" uniqKey="Mayer M" first="M." last="Mayer">M. Mayer</name>
</author>
<author><name sortKey="Merjaver, S D" sort="Merjaver, S D" uniqKey="Merjaver S" first="S. D." last="Merjaver">S. D. Merjaver</name>
</author>
<author><name sortKey="Nordstrom, E B" sort="Nordstrom, E B" uniqKey="Nordstrom E" first="E. B." last="Nordström">E. B. Nordström</name>
</author>
<author><name sortKey="Pagani, O" sort="Pagani, O" uniqKey="Pagani O" first="O." last="Pagani">O. Pagani</name>
</author>
<author><name sortKey="Partridge, A" sort="Partridge, A" uniqKey="Partridge A" first="A." last="Partridge">A. Partridge</name>
</author>
<author><name sortKey="Penault Llorca, F" sort="Penault Llorca, F" uniqKey="Penault Llorca F" first="F." last="Penault-Llorca">F. Penault-Llorca</name>
</author>
<author><name sortKey="Piccart, M J" sort="Piccart, M J" uniqKey="Piccart M" first="M. J." last="Piccart">M. J. Piccart</name>
</author>
<author><name sortKey="Rugo, H" sort="Rugo, H" uniqKey="Rugo H" first="H." last="Rugo">H. Rugo</name>
</author>
<author><name sortKey="Sledge, G" sort="Sledge, G" uniqKey="Sledge G" first="G." last="Sledge">G. Sledge</name>
</author>
<author><name sortKey="Thomssen, C" sort="Thomssen, C" uniqKey="Thomssen C" first="C." last="Thomssen">C. Thomssen</name>
</author>
<author><name sortKey="Van T Veer, L" sort="Van T Veer, L" uniqKey="Van T Veer L" first="L." last="Van'T Veer">L. Van'T Veer</name>
</author>
<author><name sortKey="Vorobiof, D" sort="Vorobiof, D" uniqKey="Vorobiof D" first="D." last="Vorobiof">D. Vorobiof</name>
</author>
<author><name sortKey="Vrieling, C" sort="Vrieling, C" uniqKey="Vrieling C" first="C." last="Vrieling">C. Vrieling</name>
</author>
<author><name sortKey="West, N" sort="West, N" uniqKey="West N" first="N." last="West">N. West</name>
</author>
<author><name sortKey="Xu, B" sort="Xu, B" uniqKey="Xu B" first="B." last="Xu">B. Xu</name>
</author>
<author><name sortKey="Winer, E" sort="Winer, E" uniqKey="Winer E" first="E." last="Winer">E. Winer</name>
</author>
</analytic>
<series><title level="j" type="main">Annals of oncology</title>
<title level="j" type="abbreviated">Ann. oncol.</title>
<idno type="ISSN">0923-7534</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Annals of oncology</title>
<title level="j" type="abbreviated">Ann. oncol.</title>
<idno type="ISSN">0923-7534</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advanced stage</term>
<term>Breast cancer</term>
<term>Consensus</term>
<term>International</term>
<term>Recommendation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>International</term>
<term>Consensus</term>
<term>Recommandation</term>
<term>Stade avancé</term>
<term>Cancer du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0923-7534</s0>
</fA01>
<fA03 i2="1"><s0>Ann. oncol.</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>CARDOSO (F.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>COSTA (A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>NORTON (L.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SENKUS (E.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>AAPRO (M.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ANDRE (F.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BARRIOS (C. H.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>BERGH (J.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>BIGANZOLI (L.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>BLACKWELL (K. L.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>CARDOSO (M. J.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>CUFER (T.)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>EL SAGHIR (N.)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>FALLOWFIELD (L.)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>FENECH (D.)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>FRANCIS (P.)</s1>
</fA11>
<fA11 i1="17" i2="1"><s1>GELMON (K.)</s1>
</fA11>
<fA11 i1="18" i2="1"><s1>GIORDANO (S. H.)</s1>
</fA11>
<fA11 i1="19" i2="1"><s1>GLIGOROV (J.)</s1>
</fA11>
<fA11 i1="20" i2="1"><s1>GOLDHIRSCH (A.)</s1>
</fA11>
<fA11 i1="21" i2="1"><s1>HARBECK (N.)</s1>
</fA11>
<fA11 i1="22" i2="1"><s1>HOUSSAMI (N.)</s1>
</fA11>
<fA11 i1="23" i2="1"><s1>HUDIS (C.)</s1>
</fA11>
<fA11 i1="24" i2="1"><s1>KAUFMAN (B.)</s1>
</fA11>
<fA11 i1="25" i2="1"><s1>KROP (I.)</s1>
</fA11>
<fA11 i1="26" i2="1"><s1>KYRIAKIDES (S.)</s1>
</fA11>
<fA11 i1="27" i2="1"><s1>LIN (U. N.)</s1>
</fA11>
<fA11 i1="28" i2="1"><s1>MAYER (M.)</s1>
</fA11>
<fA11 i1="29" i2="1"><s1>MERJAVER (S. D.)</s1>
</fA11>
<fA11 i1="30" i2="1"><s1>NORDSTRÖM (E. B.)</s1>
</fA11>
<fA11 i1="31" i2="1"><s1>PAGANI (O.)</s1>
</fA11>
<fA11 i1="32" i2="1"><s1>PARTRIDGE (A.)</s1>
</fA11>
<fA11 i1="33" i2="1"><s1>PENAULT-LLORCA (F.)</s1>
</fA11>
<fA11 i1="34" i2="1"><s1>PICCART (M. J.)</s1>
</fA11>
<fA11 i1="35" i2="1"><s1>RUGO (H.)</s1>
</fA11>
<fA11 i1="36" i2="1"><s1>SLEDGE (G.)</s1>
</fA11>
<fA11 i1="37" i2="1"><s1>THOMSSEN (C.)</s1>
</fA11>
<fA11 i1="38" i2="1"><s1>VAN'T VEER (L.)</s1>
</fA11>
<fA11 i1="39" i2="1"><s1>VOROBIOF (D.)</s1>
</fA11>
<fA11 i1="40" i2="1"><s1>VRIELING (C.)</s1>
</fA11>
<fA11 i1="41" i2="1"><s1>WEST (N.)</s1>
</fA11>
<fA11 i1="42" i2="1"><s1>XU (B.)</s1>
</fA11>
<fA11 i1="43" i2="1"><s1>WINER (E.)</s1>
</fA11>
<fA14 i1="01"><s1>European School of Oncology & Breast Unit, Champalimaud Cancer Center</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>European School of Oncology</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>European School of Oncology</s1>
<s2>Bellinzona</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Oncology and Radiotherapy, Medical University of Gdansk</s1>
<s2>Gdansk</s2>
<s3>POL</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Division of Oncology, Institut Multidisciplinaire d'Oncologie</s1>
<s2>Genolier</s2>
<s3>CHE</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Medical Oncology, Gustave-Roussy Institute</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Medicine, PUCRS School of Medicine</s1>
<s2>Porto Alegre</s2>
<s3>BRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Department of Medical Oncology, Sandro Pitigliani Oncology Centre</s1>
<s2>Prato</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Breast Cancer Clinical Program, Duke Cancer Institute</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Breast Unit, Champalimaud Cancer Center</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>University Clinic Golnik, Medical Faculty Ljubljana</s1>
<s2>Ljubljana</s2>
<s3>SVN</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center</s1>
<s2>Beirut</s2>
<s3>LBN</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>Brighton & Sussex Medical School, University of Sussex</s1>
<s2>Falmer</s2>
<s3>GBR</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>Breast Care Support Group, Europa Donna Malta</s1>
<s2>Mtarfa</s2>
<s3>MLT</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Division of Cancer Medicine, Peter MacCallum Cancer Centre</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="18"><s1>BC Cancer Agency</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="19"><s1>Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center</s1>
<s2>Houston</s2>
<s3>USA</s3>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="20"><s1>APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>19 aut.</sZ>
</fA14>
<fA14 i1="21"><s1>Program of Breast Health, European Institute of Oncology</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="22"><s1>Brustzentrum der Universität München</s1>
<s2>Munich</s2>
<s3>DNK</s3>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="23"><s1>Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="24"><s1>Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</fA14>
<fA14 i1="25"><s1>Sheba Medical Center</s1>
<s2>Tel Hashomer</s2>
<s3>ISR</s3>
<sZ>24 aut.</sZ>
</fA14>
<fA20><s1>1871-1888</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>22429</s2>
<s5>354000504540330020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>130 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0252642</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Annals of oncology</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02R</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B04C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>International</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>International</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Internacional</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Consensus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Consensus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Consenso</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Recommandation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Recommendation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Recomendación</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Stade avancé</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Advanced stage</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Estadio avanzado</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Breast cancer</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Breast disease</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Seno patología</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fN21><s1>307</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 14-0252642 INIST</NO>
<ET>ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)</ET>
<AU>CARDOSO (F.); COSTA (A.); NORTON (L.); SENKUS (E.); AAPRO (M.); ANDRE (F.); BARRIOS (C. H.); BERGH (J.); BIGANZOLI (L.); BLACKWELL (K. L.); CARDOSO (M. J.); CUFER (T.); EL SAGHIR (N.); FALLOWFIELD (L.); FENECH (D.); FRANCIS (P.); GELMON (K.); GIORDANO (S. H.); GLIGOROV (J.); GOLDHIRSCH (A.); HARBECK (N.); HOUSSAMI (N.); HUDIS (C.); KAUFMAN (B.); KROP (I.); KYRIAKIDES (S.); LIN (U. N.); MAYER (M.); MERJAVER (S. D.); NORDSTRÖM (E. B.); PAGANI (O.); PARTRIDGE (A.); PENAULT-LLORCA (F.); PICCART (M. J.); RUGO (H.); SLEDGE (G.); THOMSSEN (C.); VAN'T VEER (L.); VOROBIOF (D.); VRIELING (C.); WEST (N.); XU (B.); WINER (E.)</AU>
<AF>European School of Oncology & Breast Unit, Champalimaud Cancer Center/Lisbon/Portugal (1 aut.); European School of Oncology/Milan/Italie (2 aut.); European School of Oncology/Bellinzona/Suisse (2 aut.); Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre/New York/Etats-Unis (3 aut.); Department of Oncology and Radiotherapy, Medical University of Gdansk/Gdansk/Pologne (4 aut.); Division of Oncology, Institut Multidisciplinaire d'Oncologie/Genolier/Suisse (5 aut.); Department of Medical Oncology, Gustave-Roussy Institute/Villejuif/France (6 aut.); Department of Medicine, PUCRS School of Medicine/Porto Alegre/Brésil (7 aut.); Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital/Stockholm/Suède (8 aut.); Department of Medical Oncology, Sandro Pitigliani Oncology Centre/Prato/Italie (9 aut.); Breast Cancer Clinical Program, Duke Cancer Institute/Durham/Etats-Unis (10 aut.); Breast Unit, Champalimaud Cancer Center/Lisbon/Portugal (11 aut.); University Clinic Golnik, Medical Faculty Ljubljana/Ljubljana/Slovénie (12 aut.); NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center/Beirut/Liban (13 aut.); Brighton & Sussex Medical School, University of Sussex/Falmer/Royaume-Uni (14 aut.); Breast Care Support Group, Europa Donna Malta/Mtarfa/Malte (15 aut.); Division of Cancer Medicine, Peter MacCallum Cancer Centre/Melbourne/Australie (16 aut.); BC Cancer Agency/Vancouver/Canada (17 aut.); Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center/Houston/Etats-Unis (18 aut.); APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME/Paris/France (19 aut.); Program of Breast Health, European Institute of Oncology/Milan/Italie (20 aut.); Brustzentrum der Universität München/Munich/Danemark (21 aut.); Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney/Sydney/Australie (22 aut.); Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center/New York/Etats-Unis (23 aut.); Sheba Medical Center/Tel Hashomer/Israël (24 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Annals of oncology; ISSN 0923-7534; Royaume-Uni; Da. 2014; Vol. 25; No. 10; Pp. 1871-1888; Bibl. 130 ref.</SO>
<LA>Anglais</LA>
<CC>002B02R; 002B20E02; 002B04C</CC>
<FD>International; Consensus; Recommandation; Stade avancé; Cancer du sein</FD>
<FG>Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein</FG>
<ED>International; Consensus; Recommendation; Advanced stage; Breast cancer</ED>
<EG>Malignant tumor; Cancer; Mammary gland diseases; Breast disease</EG>
<SD>Internacional; Consenso; Recomendación; Estadio avanzado; Cáncer del pecho</SD>
<LO>INIST-22429.354000504540330020</LO>
<ID>14-0252642</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000229 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000229 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:14-0252642 |texte= ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) }}
This area was generated with Dilib version V0.6.33. |